Masaru Taniguchi spends much of his time researching Natural killer T cell, Immunology, T cell, Interleukin 12 and Interleukin 21. In his study, Cancer and Pathology is strongly linked to Antigen-presenting cell, which falls under the umbrella field of Natural killer T cell. His work in Immunology tackles topics such as Natural killer cell which are related to areas like Cancer research.
His work carried out in the field of T cell brings together such families of science as T lymphocyte and CD8. His Interleukin 12 research is multidisciplinary, incorporating elements of Innate immune system, Endogeny and Cell biology. Masaru Taniguchi focuses mostly in the field of T-cell receptor, narrowing it down to topics relating to Alpha and, in certain cases, Molecular biology, Spleen, Flow cytometry, Receptor and Sequence analysis.
Masaru Taniguchi mainly investigates Immunology, Molecular biology, Natural killer T cell, Antigen and T cell. The Immunology study combines topics in areas such as Cancer research and Transplantation. His Molecular biology study integrates concerns from other disciplines, such as Gene, T-cell receptor, Cytotoxic T cell and Antibody, Monoclonal antibody.
The concepts of his Cytotoxic T cell study are interwoven with issues in CD8 and Major histocompatibility complex. His Natural killer T cell research incorporates elements of Natural killer cell, Interleukin 12 and Cell biology. In his research, Suppressor is intimately related to Receptor, which falls under the overarching field of T cell.
The scientist’s investigation covers issues in Immunology, Natural killer T cell, Cell biology, CD1D and Biochemistry. Antigen, Immune system, Immunotherapy, Monoclonal antibody and Allergy are the core of his Immunology study. His Natural killer T cell study combines topics from a wide range of disciplines, such as Cell, Antigen-presenting cell, Inflammation, Natural killer cell and Pathology.
His Cell biology study also includes fields such as
His primary areas of study are Natural killer T cell, Immunology, Biochemistry, Cell biology and Immunotherapy. His Natural killer T cell study is concerned with Antigen in general. Immunology is closely attributed to Slit in his research.
His Biochemistry research integrates issues from Moiety and Stereochemistry. Masaru Taniguchi has researched Cell biology in several fields, including Cytotoxic T cell, Transcription factor, Cellular differentiation and Molecular biology. His study in Cytotoxic T cell is interdisciplinary in nature, drawing from both T cell, CD8 and Innate lymphoid cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.
Tetsu Kawano;Junqing Cui;Yasuhiko Koezuka;Isao Toura.
Science (1997)
Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors
Junqing Cui;Tahiro Shin;Tetsu Kawano;Hiroshi Sato.
Science (1997)
Differential tumor surveillance by natural killer (NK) and NKT cells
Mark J. Smyth;Kevin Y. T. Thia;Shayna E.A. Street;Erika Cretney.
Journal of Experimental Medicine (2000)
Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.
Jennifer L. Matsuda;Jennifer L. Matsuda;Olga V. Naidenko;Laurent Gapin;Toshinori Nakayama.
Journal of Experimental Medicine (2000)
Process for the production of a chimera monoclonal antibody
Masaru Taniguchi;Yoshikazu Lions Mansion Kurosawa;Kou-Zou Sugita.
(1985)
Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells
Tetsu Kawano;Junqing Cui;Yasuhiko Koezuka;Isao Toura.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Augmentation of Vα14 Nkt Cell–Mediated Cytotoxicity by Interleukin 4 in an Autocrine Mechanism Resulting in the Development of Concanavalin a–Induced Hepatitis
Yoshikatsu Kaneko;Michishige Harada;Tetsu Kawano;Masakatsu Yamashita.
Journal of Experimental Medicine (2000)
Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. IV. Special subregion assignment of the gene(s) that codes for the suppressive T-cell factor in the H-2 histocompatibility complex.
Tomio Tada;Tomio Tada;Masaru Taniguchi;Masaru Taniguchi;Chella S. David.
Journal of Experimental Medicine (1976)
Disruption of the Bcl6 Gene Results in an Impaired Germinal Center Formation
Tetsuya Fukuda;Takehiko Yoshida;Seiji Okada;Masahiko Hatano.
Journal of Experimental Medicine (1997)
Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
Nicolas Burdin;Laurent Brossay;Yasuhiko Koezuka;Stephen T. Smiley.
Journal of Immunology (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Chiba University
RIKEN Center for Integrative Medical Sciences
Chiba University
University of Tsukuba
University of Tokyo
Juntendo University
University of Tokyo
Ehime University
Tohoku University
Nagoya City University
Altos Labs
University of Sheffield
University of Tokyo
University of Utah
University of Massachusetts Amherst
University of California, San Diego
Ghent University
The Ohio State University
National Oceanic and Atmospheric Administration
Baylor College of Medicine
Memorial Sloan Kettering Cancer Center
University of Lausanne
University of California, Berkeley
University of Melbourne
University of Pennsylvania
University of La Serena